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Abstract In professional soccer and other elite sports,
medical and performance screening of athletes (also termed
periodic health examination or PHE) is common practice.
The purposes of this are: (1) to assist in identifying
prevalent conditions that may be a threat to safe partici-
pation, (2) to assist in setting benchmark targets for reha-
bilitation or performance purposes and (3) to assist
clinicians in determining which athletes may be at risk of
future injury and selecting appropriate injury prevention
strategies to reduce the perceived risk. However, when
using PHE as an injury prevention tool, are clinicians
seeking to identify potential causes of injury or to predict
future injury? This Current Opinion aims to examine the
conceptual differences between aetiology and prediction of
injury while relating these areas to the capabilities of PHE
in practice. We also introduce the concept of prognosis—a
broader approach that is closely related to prediction—and
why this may have greater applicability to PHE of pro-
fessional athletes.
Key Points
Periodic health examination (PHE) is commonly
used in professional football and other elite sports to
provide baseline physical measurements for
rehabilitation or performance purposes and to assist
in selection of injury prevention practices.
PHE is often used to identify possible contributing
causal factors for injury. However, due to issues with
analysis and confounding, this is unachievable.
Using PHE for injury risk prediction is theoretically
achievable, but we suggest that using the related
concept of prognosis is arguably more appropriate
for professional athletes.
1 Introduction
A 32-year-old professional football player is sprinting
towards the goal. He feels sudden pain in his right ham-
string, falls to the ground and cannot continue. Medical
assessment reveals a torn right semimembranosus and he
will miss the rest of the season. The medical staff might ask
themselves: ‘‘Could our screening processes have identified
possible causal factors or maybe predicted this injury?
Could we have prevented it?’’
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The phrase ‘‘an ounce of prevention is better than a
pound of cure’’ is as relevant as never before. In elite
professional team sports such as football, preventing an
injury is big business. For every player missing through
injury the cost to an elite football team is approximately
€20,000 (US$24,000) per day [1]. Limiting time lost
through injury has significant positive implications for
team performance [2] with successful teams and individual
players receiving vast commercial and financial rewards
[2, 3].
In elite sport, a key component of injury prevention
practice is medical and performance screening, also ter-
med periodic health examination (PHE) [4]. In European
professional football, 94% of teams conduct PHE which
usually consists of medical, musculoskeletal examination
and performance tests during pre-season and in-season
periods [5]. As well as providing regular health surveil-
lance, PHE has other potential benefits, such as identifi-
cation of prevalent musculoskeletal or medical pathology
that may prohibit safe participation or limit performance
[6]. PHE can also provide baseline measures to which
clinicians can refer and monitor progress through reha-
bilitation should a player become injured and which sports
scientists can use as markers for training response. PHE
has an integral role in development of injury prevention
strategies [7, 8]. Traditionally PHE has been used to
identify factors that are potentially related to mechanisms
causing pathology and guide early management of these
factors [8]. Additionally, PHE can be used as a predictive
tool to identify and manage factors or performance
impairments [4] that could be associated with increased
injury risk [6], even if they do not always contribute to the
cause of injuries.
Using PHE to find and fix a potential problem before it
happens seems a simple and logical approach, but in reality
it is fraught with complexity. As such, not all PHE pro-
grammes are beneficial to athletes who have been evalu-
ated [4, 6], which could be due to several reasons. Because
of the relatively small number of injuries that occur in elite
sport populations compared to the general population, there
is limited evidence to guide practitioners in selection of
valid, reliable, sensitive and specific tests appropriate for
elite athletes [6]. A related issue is that for tests included in
PHE batteries, establishing thresholds to determine whe-
ther athletes are considered as high or low risk can be
problematic [4]. Psychological factors may be associated
with musculoskeletal injuries and could have an important
role in injury prevention [9, 10], although current PHE
guidelines do not provide specific recommendations in
terms of psychological evaluation [6]. Importantly, confu-
sion with terminology and blurring of the complicated
theoretical concepts of injury aetiology (investigation of
cause) and prediction (investigation of future outcomes)
within the literature and at a practical clinical level also
mean it is difficult for clinicians to fully appreciate the
capabilities and limitations of PHE in injury prevention.
Therefore, the aim of this Current Opinion article is to
examine the conceptual differences between aetiology and
prediction, whilst highlighting their relevance to PHE in
professional football and other sports.
2 Periodic Health Examination (PHE)
as an Aetiological Screening Model—the
Impossible Goal?
Aetiological research investigates mechanisms or factors
that may cause injury, primarily using cohort studies
[11, 12]. PHE is frequently perceived to be able to do the
same: to identify likely causal factors that elevate the risk
of future injury in a cohort of athletes. Clinicians may
develop specific injury prevention strategies designed to
modify such potentially causal factors [8] and therefore
affect a reduction of the risk of a future injury [13, 14]. In
our example (Fig. 1), suppose the player demonstrated
reduced hamstring length (A) on the right leg during the
muscle length testing component of PHE. It is tempting to
assume that this was a cause of the hamstring injury (B).
However, this interpretation is too simplistic.
A causal factor of an individual injury is any charac-
teristic, variable or condition that must have been present
before or at injury onset such that, if the frequency, value
or quality of the factor was different in a particular way, the
injury may not have occurred or it may have occurred after
a latent period [15, 16]. With the exception of traumatic,
impact-related injuries, individual causal factors are unli-
kely to cause an injury independently; most injuries are due
to multiple factors [13]. Some factors may have a strong or
weak influence on the risk of injury [17] and the relative
influence of each is dynamic, often changing over time
[13]. To confirm factors as causal (such as those investi-
gated during PHE), a body of high quality evidence is
required [12], but this is currently lacking for injuries
specifically in professional football [18, 19] and is of
variable quality in other sports [20–27]. Studies that
Fig. 1 Diagram to show a simple causal pathway between hamstring
length and hamstring injury, with age as a confounding factor
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investigate causal factors should provide detailed method-
ology and design, explicit definitions and measurement
criteria for causal factors, confounding factors and patho-
logical outcomes. These are outlined in reporting guideli-
nes such as the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) state-
ment [28].
A term frequently used in epidemiology is confounding.
A confounding factor, put simply, is another variable that
confuses our understanding of the relationship between
what we think is a causal factor and the outcome. To be
considered as a confounder, the variable must be associated
with the injury outcome in its own right but also have an
association with the supposed causal factor under investi-
gation (e.g. observed in a PHE test) [29, 30]. In our
example (Fig. 1), during PHE our player demonstrated
reduced hamstring length. If it is assumed that reduced
hamstring length (A) could be a causal factor for hamstring
injury (B), age-related physiological muscular changes
could be viewed as a confounding factor (C). A possible
explanation is that age-related physiological changes could
adversely affect hamstring length, but also may influence
the risk of hamstring injury independently.
Other typical examples of confounders are ethnicity,
height and gender. Confounding may lead to incorrect
estimates of the association between a factor and injury and
thereby distort our view of what may cause an injury if we
do not appropriately account for them. Although not the
focus of this article, confounding is usually controlled for
in observational studies through study design methods (e.g.
stratification and restriction) or multivariable statistical
analysis (adjustment of the association) [12]. However,
these methods cannot account for unknown or unmeasured
confounding factors. Therefore, even in robust observa-
tional studies, it is nearly impossible to completely elimi-
nate the influence of confounding factors [31].
It is acknowledged that in this Current Opinion, we have
presented a simplification of causal factor and confounding
relationships to injuries in order to maintain a clinical
focus. However, these relationships usually have even
greater complexity and, in particular, may include medi-
ating factors (which may exist between a causal factor and
outcome) and moderating factors (interactions between two
factors). For detailed information about such complexities
in terms of causation, readers are advised to refer to Cor-
raini et al. [32] and Rothman, Greenland and Lash [16].
When PHE is conducted in practice, because of the basic
descriptive statistical methods used, the absence of a strong
evidence base to underpin PHE as a tool to assess possible
causes of injury whilst not controlling for confounding
factors, can we realistically expect PHE to inform clini-
cians about the possible causes of injury and therefore
guide injury prevention strategies? We would suggest not.
3 PHE as a Prediction/Prognostic Screening
Model—the Possible Goal
Prediction research is the investigation of the probability or
risk of future health outcomes over time using both clinical
and non-clinical information [11, 33]. Similar to aetiolog-
ical research, prediction research questions are usually
addressed through cohort studies [11]. In sports medicine,
this concept is also frequently perceived to be an aim of
PHE when used for injury prevention; that is, evaluating
asymptomatic athletes to establish whether some mea-
surements may predict future injury [4]. The capabilities of
PHE for injury prediction purposes have recently been
questioned, because the continuous nature of data obtained
from many tests mean it is difficult to determine appro-
priate cut-off points that categorise athletes into high or
low-risk groups [4]. However, even though PHE may never
be able to perfectly dichotomise or categorise athletes into
those who will and those who will not experience injury,
the information it gathers can still have predictive value
[34].
Viewing professional, elite athletes as healthy or
asymptomatic at the time of PHE may also have limited
validity. They are not representative of the general popu-
lation and place abnormal physical load on their bodies.
The vast majority have experienced musculoskeletal inju-
ries as a consequence of high-level training and competi-
tion exposure. As a result, multifactorial prevalent or
transient chronic musculoskeletal disorders are common in
sport [8], and may present in athletes at the time of PHE.
Such disorders are frequently managed through medical
means, exercise or training load modification, which allows
high-level function with reduced or tolerable symptoms.
Therefore, a related and broader concept for sports
medicine to consider is prognosis. Traditionally in medical
language, ‘prognosis’ commonly refers to the expected
course of an individual’s illness or injury, although this has
been viewed as too general and has only limited clinical
application [33]. Prognostic research, however, aims to
understand and predict future outcomes in those with an
existing condition or baseline health state (e.g. previous
injury) that warrants medical or clinical evaluation [35].
This is applicable to PHE and means that at the time of
assessment, if an athlete has had a previous injury or
existing condition, or if being an elite athlete can indeed be
considered a condition in itself, PHE can be used to
investigate an athlete’s prognosis in terms of sustaining
future injuries.
Prognosis research can suffer from methodological
flaws, including insufficient reporting of methodology,
participation rate and outcomes, for example, which have
led to erroneous conclusions and significant consequences
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in medical practice [36]. In response, the PROGnosis
RESearch Strategy (PROGRESS) Partnership has been
formed, which is an international, interdisciplinary col-
laboration that aims to enhance the transparency, quality
and impact of prognosis research [35]. PROGRESS have
proposed a framework of four different types of prognosis
research for people with a particular condition or starting
point of interest: (1) summary of overall outcome risk; (2)
identification of factors that are associated with (and
therefore explain) changes in outcome risk across indi-
viduals; (3) development and validation of prognostic
models that predict individual outcome risk conditional on
multiple factors; and (4) the identification of factors and
tests that predict individual response to a particular treat-
ment (stratified medicine) [14, 35–38]. PROGRESS
demonstrate the importance of improved prognosis
research methods, in particular for large confirmatory
studies to identify factors associated with health outcomes;
more appropriate statistical analyses to develop and vali-
date models for individual risk of future outcomes; and
improved ways to utilise prognosis research information to
impact upon individualised treatment or management
strategies.
The PROGRESS framework is reflective of the aims of
PHE when used in terms of injury prevention and can help
to guide development of robust and high-quality PHE
processes. When considering our example, the ‘summary’
component (overall prognosis) may quantify the proportion
of footballers who develop hamstring muscle injuries by
the end of a season and therefore provide information on
clinically important outcomes. The ‘explain’ component
relates to the identification of prognostic factors (measured
through PHE) that are associated with hamstring injury risk
across individuals. The ‘predict’ component relates to
using several of these factors (also measured through PHE)
in a prognostic model to predict hamstring injury risk for
an individual and select specific management strategies to
modify the risk.
Factors associated with injury and assessed through PHE
have been given various names within the literature, which
is also a source of confusion. The term ‘risk factor’ is often
used but this can mean that such factors are causal [39, 40],
whether this is intentional or not, and we would argue that
it is more suited to the aetiological model. However, in
those with existing conditions (such as elite football play-
ers), PROGRESS recommends using the term ‘prognostic
factors’ (PFs), defined as any variable that is associated
with (predictive of) clinical events (such as injury) in
populations with a defined baseline state [14, 35]. We
prefer the PROGRESS definition for outcomes in sports
medicine, as it reflects that importantly, both causal and
non-causal factors can be a PF, as long as they provide
information that contributes toward outcome prediction
[14]. Again, this is also more reflective of PHE in profes-
sional football, as there are no clear causal links between
PHE assessment and injuries [18]. One of the objectives of
prognosis research is to combine several PFs within a
multivariable prognostic (or prediction) model to deter-
mine the absolute risk of an injury for an individual
[14, 38]. These models can guide selection of tailored
management strategies based on each individual risk esti-
mate and PF profile [38]. This approach can translate to
PHE in practice and is different to the traditional PHE
injury prevention paradigm, where prevention strategies
are selected based on whether an abnormal PHE finding
could be a known or assumed causal factor for injury [8]. In
contrast to aetiology, confounding becomes less problem-
atic in prognosis, as potential confounders (if known) are
prognostic factors in their own right, and can be included in
a prognostic model if they sufficiently contribute to out-
come prediction [14]. If we want to know the risk of an
injury occurring, it is unimportant whether this is estimated
using causal or non-causal factors and there is no necessity
to unravel or eliminate these relationships [11, 12]. The key
thing is that the developed prognostic (prediction) model is
sufficiently accurate to help inform a player’s management.
This approach is appropriate to PHE in elite sport
because any factor, test or measurement performed on
players could be statistically analysed to estimate its value
as a PF, both individually and in combination with other
factors within a prognostic model. So, in our example
(Fig. 1), a prognostic model might include both reduced
hamstring length and age, as the confounding relationship
is no longer important. As such, individual clubs could
select bespoke PHE test batteries through either experien-
tial or evidence-based means, and clinicians could evaluate
whether any aspect of their selected PHE has prognostic
value. This could improve time and service efficiency as
PHE batteries could be streamlined to include only those
tests that have confirmed prognostic value, as well as tests
considered important for rehabilitation or performance
purposes. Using a smaller selection of tests based upon a
prognostic model may allow more regular PHE assessment
and evaluation of changing levels of absolute risk over
time. Identification of PFs could assist development of
innovative PHE tests in future [37].
Despite these benefits, there are also challenges to
consider when utilising prognostic models within sports
medicine. The quality of data used to develop a model is
critical to its performance [38, 41], so tests chosen for a
club’s PHE process should be reliable and precise. Accu-
rate injury outcome identification is imperative, using
clinical criteria or gold standard diagnostic measures where
possible, to reduce the effects of outcome misclassification
[18, 42, 43]. Once developed, models should be validated
internally, where predictive performance is tested on the
T. Hughes et al.
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dataset from which it was derived (e.g. using a resampling
technique such as bootstrapping) with adjustments for
overfitting/optimism made [44]. Ideally, validation should
be completed externally on data from a sample from
another location [38], but when considering our example,
this would mean another football club. This, however, is
unrealistic in the world of elite-level sports because
achieving or maintaining a competitive edge is key, so all
that matters in these situations is that predictive perfor-
mance is acceptable and informative in the local setting.
Although an accurate prognostic model can assist clin-
icians in healthcare delivery, in order to be useful they
should be easy to implement in clinical practice [38] and be
directly relevant to the clinician’s available skillset and
resources [45]. Using our example, if we could create a
model that included hamstring length assessment as a PF
for a structural hamstring injury, then clinicians would
have consistent methods of hamstring length assessment, in
addition to accurate and reliable diagnostic measures (such
as imaging) to prevent misclassification. Importantly,
although statistical models can be useful, they are a theo-
retical construct developed under scientific or mathemati-
cal assumptions whilst using real data. Although assumed
to represent the real world, this may not necessarily be the
case and so require a degree of cautiousness and pragma-
tism with interpretation [46]; prognostic models should
help clinical decision making and not be seen as a
replacement for this process [47].
4 Conclusion and Recommendations
After the football player’s hamstring tear, the medical staff
asked themselves: Firstly, could PHE have identified the
cause of the injury? It is improbable that PHE would allow
identification of the cause with certainty. Secondly, could
they have predicted the injury risk using PHE? This is
theoretically achievable, although currently the role of
PHE in injury prognosis (or prediction) is unsubstantiated
in professional football due to significant shortcomings in
the quality and quantity of the current evidence [18].
Although further research is clearly essential to improve
our understanding of this area, the discussed concepts
based on our current knowledge have significant implica-
tions. If the aim of PHE is to set benchmarks for rehabil-
itation or performance targets, then the aetiology versus
prognosis (prediction) debate is irrelevant. However, if
PHE is to be used to inform injury prevention strategies,
then we need to be explicit whether we are investigating
cause or prognosis (prediction). We advocate applying the
PROGRESS framework to PHE and using clear terminol-
ogy. Instead of using terms such as risk factor, we should
use prognostic factor for factors associated with outcomes,
whether causal or non-causal, and reserve the term ‘causal
factor’ for the rare occasions when we have the evidence to
justify its use.
It is hoped that this Current Opinion may help dispel the
myth that injury causality can be routinely established
through PHE. Instead, using the fundamentals of prognosis
research can allow a data-guided, bespoke estimation of
risk and inform possible injury prevention rather than being
led by limited evidence, unconfirmed hypotheses and
clinical intuition alone.
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